Skip to main content

Pharmaceuticals

Enabling quick and smart access to Pharmaceuticals ingredients, we bring API expertise with a worldwide sourcing, and have a certified Excipients experience. Either you are looking for Veterinary API’s, Human API’s, Excipients, API Impurities, you can find them quickly by browsing our online catalog.

Pharmaceuticals

193 results for Pharmaceuticals
CLEAR ALL
Actylis
Excipient developed for use in pharmaceutical applications.
Actylis
Excipient for use in pharmaceutical applications.
Actylis
Excipient for use in pharmaceutical applications.
Actylis
Excipient for use in pharmaceutical applications.
Actylis
Excipient for pharmaceutical applications.Benefits:
  • Effloresces in warm, dry air. Its solutions are alkaline to phenolphthalein TS, a 0.1 M solution having a pH of about 9
  • Freely soluble in water, very slightly soluble in alcohol
Actylis
Excipient recommended for pharmaceutical applications.
Actylis
Coating agent developed for solid and semi-solid dosage forms.Benefits:
  • Strong control on all possible impurities along with ICH Q3D compliance for R&D to commercial manufacturing
Actylis
Coating agent developed for solid and semi-solid dosage forms.Benefits:
  • Strong control on all possible impurities along with ICH Q3D compliance for R&D to commercial manufacturing
Actylis
Coating agent developed for solid and semi-solid dosage forms.Benefits:
  • Strong control on all possible impurities along with ICH Q3D compliance for R&D to commercial manufacturing
Actylis
Coating agent developed for solid and semi-solid dosage forms.Benefits:
  • Strong control on all possible impurities along with ICH Q3D compliance for R&D to commercial manufacturing
Actylis
Excipient designed for use in pharmaceutical applications.
Actylis
Excipient designed for use in pharmaceutical applications.
Actylis
Excipient recommended for pharmaceutical applications.
Actylis
Excipient applicable in pharmaceutical applications.
Actylis
Excipient for use in pharmaceutical applications.
Actylis
Solvent/ Co-solvent developed exclusively for use in injectable formulations.Benefits:
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
  • DMF Filed - CDE # F20190000639